"What" Series

What is Disease-Specific Survival (DSS) in Clinical Trials?

16 October 2023
2 min read

Disease-Specific Survival (DSS) refers to deaths caused specifically by a particular disease. At this point, there is concern whether the cause of death is directly attributable to the specific disease. If it is not caused by the specific disease, it is not included in the outcome index. The DSS can successfully reflect the clinical benefits of a specific disease, and show whether deaths caused by the specific disease have decreased or increased. However, the cause of death in patients is often unclear, requiring professionals to analyze.

Nature releases preclinical outcomes for ABBV-CLS-484, a PTPN2/N1 inhibitor in Cancer Immunotherapy
Latest Hotspot
4 min read
Nature releases preclinical outcomes for ABBV-CLS-484, a PTPN2/N1 inhibitor in Cancer Immunotherapy
16 October 2023
Nature reported on a discovery by AbbVie, the Broad Institute, and Calico Life Sciences. Their research indicates the potential of ABBV-CLS-484, an experimental drug, to act as a PTPN2/N1 phosphatase inhibitor boosting anti-cancer immunity, orally administered.
Read →
What is Milestone Survival in Clinical Trials?
"What" Series
2 min read
What is Milestone Survival in Clinical Trials?
16 October 2023
Milestone survival rate is defined as the survival probability at a given point in time.
Read →
Moderna Unveils Phase 1/2 Results for mRNA-1083
Latest Hotspot
3 min read
Moderna Unveils Phase 1/2 Results for mRNA-1083
16 October 2023
Moderna, Inc. reported encouraging preliminary outcomes from the mRNA-1083 Phase 1/2 study, a combination vaccine currently under investigation for its effect against both influenza and COVID-19.
Read →
What is Health-related Quality of Life (HRQoL) in Clinical Trials?
"What" Series
2 min read
What is Health-related Quality of Life (HRQoL) in Clinical Trials?
16 October 2023
Health-Related Quality of Life (HRQoL) is a significant indicator for assessing the quality of life and health status of patients.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.